SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-08-100936
Filing Date
2008-05-02
Accepted
2008-05-02 17:24:37
Documents
7
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 559103
2 FORM OF PERFORMANCE SHARE AWARD AGREEMENT dex1060.htm EX-10.60 87050
3 MASTER CONFIRMATION dex1061.htm EX-10.61 161761
4 TENOFOVIR DISOPROXIL FUMARATE MANUFACTURING SUPPLY AGREEMENT dex1062.htm EX-10.62 106534
5 CERTIFICATION OF CEO AS REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) dex311.htm EX-31.1 8016
6 CERTIFICATION OF CFO AS REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) dex312.htm EX-31.2 8089
7 CERTIFICATION OF CEO AND CFO AS REQUIRED BY RULE 13A-14(B) OR 15D-14(B) dex32.htm EX-32 4362
  Complete submission text file 0001193125-08-100936.txt   936310
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Filer) CIK: 0000882095 (see all company filings)

IRS No.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19731 | Film No.: 08800154
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1